Display options
Cite
Anyanwu MU, Okoye RC. Antimicrobial activity of Nigerian medicinal plants. J Intercult Ethnopharmacol. 2017;6(2):240-259doi: 10.5455/jice.20170106073231.
Anyanwu, M. U., & Okoye, R. C. (2017). Antimicrobial activity of Nigerian medicinal plants. Journal of intercultural ethnopharmacology, 6(2), 240-259. https://doi.org/10.5455/jice.20170106073231
Anyanwu, Madubuike Umunna, and Okoye, Rosemary Chinazam. "Antimicrobial activity of Nigerian medicinal plants." Journal of intercultural ethnopharmacology vol. 6,2 (2017): 240-259. doi: https://doi.org/10.5455/jice.20170106073231
Anyanwu MU, Okoye RC. Antimicrobial activity of Nigerian medicinal plants. J Intercult Ethnopharmacol. 2017 Feb 18;6(2):240-259. doi: 10.5455/jice.20170106073231. eCollection 2017. PMID: 28512606; PMCID: PMC5429085.
Copy Download .nbib Format: NLM
Share it on

J Intercult Ethnopharmacol. 2017 Feb 18;6(2):240-259. doi: 10.5455/jice.20170106073231. eCollection 2017.

Antimicrobial activity of Nigerian medicinal plants.

Journal of intercultural ethnopharmacology

Madubuike Umunna Anyanwu, Rosemary Chinazam Okoye

Affiliations

  1. Department of Veterinary Pathology and Microbiology, University of Nigeria, Nsukka, Nigeria.
  2. Department of Biological Sciences, Federal University Otuoke, Bayelsa State, Nigeria.

PMID: 28512606 PMCID: PMC5429085 DOI: 10.5455/jice.20170106073231

Abstract

Antimicrobial resistance (AMR) is currently one of the major threats facing mankind. The emergence and rapid spread of multi- and pan-drug-resistant organisms (such as vancomycin-, methicillin-, extended-spectrum β-lactam-, carbapenem- and colistin-resistant organisms) has put the world in a dilemma. The health and economic burden associated with AMR on a global scale are dreadful. Available antimicrobials have been misused and are almost ineffective with some of these drugs associated with dangerous side effects in some individuals. Development of new, effective, and safe antimicrobials is one of the ways by which AMR burden can be reduced. The rate at which microorganisms develop AMR mechanisms outpaces the rate at which new antimicrobials are being developed. Medicinal plants are potential sources of new antimicrobial molecules. There is renewed interest in antimicrobial activities of phytochemicals. Nigeria boasts of a huge heritage of medicinal plants and there is avalanche of researches that have been undertaken to screen antimicrobial activities of these plants. Scientific compilation of these studies could provide useful information on the antimicrobial properties of the plants. This information can be useful in the development of new antimicrobial drugs. This paper reviews antimicrobial researches that have been undertaken on Nigerian medicinal plants.

Keywords: Antimicrobial activity; Nigerian medicinal plants; antimicrobial resistance

References

  1. Clin Microbiol Rev. 1999 Oct;12(4):564-82 - PubMed
  2. Phytother Res. 1999 Dec;13(8):675-9 - PubMed
  3. J Ethnopharmacol. 1999 Nov 1;67(2):225-8 - PubMed
  4. J Appl Microbiol. 2000 May;88(5):784-90 - PubMed
  5. Environ Health Perspect. 2001 Mar;109 Suppl 1:69-75 - PubMed
  6. J Clin Microbiol. 2001 Apr;39(4):1345-7 - PubMed
  7. J Ethnopharmacol. 2001 Jul;76(2):177-82 - PubMed
  8. Anal Bioanal Chem. 2002 May;373(1-2):23-30 - PubMed
  9. J Clin Microbiol. 2003 Nov;41(11):5236-7 - PubMed
  10. Nat Prod Rep. 2004 Apr;21(2):263-77 - PubMed
  11. J Ethnopharmacol. 2004 Oct;94(2-3):205-17 - PubMed
  12. BMJ. 2004 Nov 13;329(7475):1156-9 - PubMed
  13. J Ethnopharmacol. 2005 Feb 10;97(1):107-15 - PubMed
  14. J Clin Microbiol. 2005 Mar;43(3):1251-5 - PubMed
  15. BMC Complement Altern Med. 2005 Mar 11;5:6 - PubMed
  16. J Antimicrob Chemother. 2005 May;55(5):699-706 - PubMed
  17. J Ethnopharmacol. 2005 Aug 22;100(1-2):80-4 - PubMed
  18. J Ethnopharmacol. 2005 Aug 22;100(1-2):124-6 - PubMed
  19. J Ethnopharmacol. 2005 Aug 22;100(1-2):23-6 - PubMed
  20. Phytother Res. 2005 Apr;19(4):310-3 - PubMed
  21. Phytother Res. 2005 Apr;19(4):362-4 - PubMed
  22. Mol Aspects Med. 2006 Feb;27(1):1-93 - PubMed
  23. J Contemp Dent Pract. 2005 Aug 15;6(3):86-94 - PubMed
  24. J Ethnopharmacol. 2006 Mar 8;104(1-2):164-7 - PubMed
  25. Am J Med. 2006 Jun;119(6 Suppl 1):S3-10; discussion S62-70 - PubMed
  26. Phytother Res. 2007 Jan;21(1):67-71 - PubMed
  27. West Indian Med J. 2006 Sep;55(4):219-23 - PubMed
  28. J Zhejiang Univ Sci B. 2007 May;8(5):352-8 - PubMed
  29. Nat Protoc. 2008;3(2):163-75 - PubMed
  30. J Ethnopharmacol. 2008 Oct 28;119(3):462-72 - PubMed
  31. Curr Pharm Biotechnol. 2009 Jan;10(1):86-105 - PubMed
  32. Afr J Tradit Complement Altern Med. 2007 Feb 16;4(3):338-44 - PubMed
  33. Afr J Tradit Complement Altern Med. 2008 Apr 10;5(3):226-9 - PubMed
  34. Afr J Tradit Complement Altern Med. 2006 Nov 13;4(2):173-84 - PubMed
  35. J Dent Res. 2010 Jun;89(6):561-70 - PubMed
  36. Clin Infect Dis. 2010 Apr 15;50(8):1081-3 - PubMed
  37. J Ethnopharmacol. 2011 Jan 27;133(2):289-302 - PubMed
  38. Indian J Pharm Sci. 2010 May;72(3):334-9 - PubMed
  39. Gut Microbes. 2010 Jan;1(1):4-21 - PubMed
  40. J Ethnopharmacol. 2011 Sep 1;137(1):50-6 - PubMed
  41. Front Microbiol. 2010 Dec 08;1:134 - PubMed
  42. Afr J Tradit Complement Altern Med. 2010;7(4):303-6 - PubMed
  43. Medicina (Kaunas). 2011;47(3):137-46 - PubMed
  44. Pak J Pharm Sci. 2011 Oct;24(4):475-8 - PubMed
  45. Org Med Chem Lett. 2011 Oct 04;1(1):14 - PubMed
  46. Rev Biol Trop. 2012 Dec;60(4):1535-42 - PubMed
  47. Indian J Dermatol Venereol Leprol. 2013 May-Jun;79(3):389-98 - PubMed
  48. BMC Complement Altern Med. 2013 Jun 26;13:147 - PubMed
  49. Arch Dis Child. 2013 Dec;98(12):998-1003 - PubMed
  50. Front Microbiol. 2013 Aug 22;4:233 - PubMed
  51. BMC Complement Altern Med. 2013 Oct 29;13:291 - PubMed
  52. Antimicrob Resist Infect Control. 2013 Nov 18;2:31 - PubMed
  53. Nat Prod Bioprospect. 2014 Feb;4(1):1-19 - PubMed
  54. Int J Biomed Sci. 2014 Mar;10(1):25-30 - PubMed
  55. Cell. 2014 Apr 24;157(3):539-48 - PubMed
  56. BMC Complement Altern Med. 2014 May 13;14:157 - PubMed
  57. J Ethnopharmacol. 2014 Aug 8;155(1):524-32 - PubMed
  58. Evid Based Complement Alternat Med. 2015;2015:684839 - PubMed
  59. PLoS One. 2015 Feb 26;10(2):e0118431 - PubMed
  60. Molecules. 2015 Mar 24;20(4):5286-98 - PubMed
  61. BMC Complement Altern Med. 2015 Mar 10;15:53 - PubMed
  62. BMC Infect Dis. 2015 Mar 15;15:127 - PubMed
  63. New Microbes New Infect. 2015 Apr 16;6:22-9 - PubMed
  64. J Intercult Ethnopharmacol. 2015 Jul-Sep;4(3):239-48 - PubMed
  65. Lancet Infect Dis. 2016 Apr;16(4):388-9 - PubMed
  66. Front Microbiol. 2016 Apr 08;7:470 - PubMed
  67. Molecules. 2016 Apr 29;21(5): - PubMed
  68. Lancet Infect Dis. 2016 Jul;16(7):767-768 - PubMed
  69. Vet Dermatol. 2017 Feb;28(1):82-e19 - PubMed
  70. Afr J Biomed Res. 2013 Jan;16(1):19-24 - PubMed
  71. Antimicrob Agents Chemother. 1988 Apr;32(4):598-600 - PubMed
  72. J Pharm Anal. 2016 Apr;6(2):71-79 - PubMed
  73. Planta Med. 1987 Oct;53(5):395-8 - PubMed
  74. J Med Microbiol. 1987 Feb;23(1):55-60 - PubMed
  75. Planta Med. 1979 Jul;36(3):204-7 - PubMed
  76. Caries Res. 1984;18(3):216-25 - PubMed
  77. J Ethnopharmacol. 1998 Feb;60(1):1-8 - PubMed
  78. J Ethnopharmacol. 1998 Feb;60(1):79-84 - PubMed
  79. Afr Dent J. 1995;9:15-9 - PubMed

Publication Types